does taking semaglutide affect your period and Period: What Science Says Semaglutide and Menopause: Does It

Intriguingly, the fast and transient increase of [Ca 2+ ] cyt was notably triggered in systemic leaves (including leaf 3, 4, and 6) by GSH (Supplementary Movie 3) at the level comparable to that induced by Glu (Fig

At a glance Platform type / Women-focused GLP-1 telehealth + dietitian coaching Primary medication / Semaglutide (oral or injectable, dose-titrated) Regulatory basis / GLP-1 prescribing follows FDA-approved indications for BMI 30 or BMI 27 with a weight-related comorbidity Hard contraindications / Personal or family history of MTC or MEN2, pregnancy, active anorexia or bulimia Key safety signal / GLP-1 agents carry an FDA boxed warning for thyroid C-cell tumors in rodents Complaint pattern / Most documented complaints relate to cancellation difficulty and billing, not clinical harm Trial benchmark / STEP-1 (N=1,961): semaglutide 2.4 mg produced 14.9% mean body-weight loss at 68 weeks vs

Dal Negro RW, Wedzicha JA, Iversen M, et al

In September 2025 the FDA issued warning letters to more than 50 GLP-1 compounders and specifically targeted six companies for selling products containing retatrutide